Fericma

Description

Fericma 500 Injection contains Ferric Carboxymaltose Injection 500 mg / 10 ml (50 mg/ml), manufactured and marketed by Albizia Life Science.

Fericma 500 effectively addresses all types of iron deficiency and iron deficiency anemia (IDA), rapidly restoring iron stores and hemoglobin levels.

Key Clinical Advantages & Features:
– Rapid Correction of Anemia: FCM is highly effective in correcting iron deficiency (ID) and iron deficiency anemia caused by chronic abnormal uterine bleeding (AUB) within 6 weeks.
– Proven Safety Profile: Well-tolerated with no risk of toxicity or anaphylactic shock reported.
– Superior Formulation: Contains minimal free iron, no dextran, and a higher molecular weight (MW) for maximum therapeutic efficacy.
– Quality Assured: Produced under stringent quality control for CM-API, ensuring uniform consistency in each batch.

Composition:
– Ferric Carboxymaltose 500 mg / 10 ml (50 mg/ml)

Dosage & Administration:
For intravenous (IV) infusion or slow IV injection only. To be administered strictly under medical supervision.